Search Results - "te Morsche, René H M"

Refine Results
  1. 1

    Heterozygosity of ALG9 in Association with Autosomal Dominant Polycystic Liver Disease by Boerrigter, Melissa M, Duijzer, Renée, te Morsche, René H. M, Drenth, Joost P. H

    Published in Genes (01-09-2023)
    “…α-1,2-mannosyltransferase (ALG9) germline variants are linked to autosomal dominant polycystic kidney disease (ADPKD). Many individuals affected with ADPKD…”
    Get full text
    Journal Article
  2. 2

    Loss of heterozygosity is present in SEC63 germline carriers with polycystic liver disease by Janssen, Manoe J, Salomon, Jody, Te Morsche, René H M, Drenth, Joost P H

    Published in PloS one (28-11-2012)
    “…Polycystic liver disease (PCLD) is an autosomal dominant disorder characterised by multiple fluid filled cysts in the liver. This rare disease is caused by…”
    Get full text
    Journal Article
  3. 3

    Novel α-1,3-Glucosyltransferase Variants and Their Broad Clinical Polycystic Liver Disease Spectrum by Boerrigter, Melissa M, Te Morsche, René H M, Venselaar, Hanka, Pastoors, Nikki, Geerts, Anja M, Hoorens, Anne, Drenth, Joost P H

    Published in Genes (19-08-2023)
    “…Protein-truncating variants in α-1,3-glucosyltransferase ( ) are a risk factor for a mild cystic kidney disease phenotype. The association between these…”
    Get full text
    Journal Article
  4. 4

    Paroxysmal extreme pain disorder: a molecular lesion of peripheral neurons by Waxman, Stephen G, Choi, Jin-Sung, Boralevi, Franck, Brissaud, Olivier, Sánchez-Martín, Jesús, te Morsche, René H. M, Dib-Hajj, Sulayman D, Drenth, Joost P. H

    Published in Nature reviews. Neurology (01-01-2011)
    “…Choi et al . describe the case of a 3 month-old infant who, on the second day of life, had begun to experience painful paroxysmal events starting with tonic…”
    Get full text
    Journal Article
  5. 5

    Effect of a specific cyclooxygenase-gene polymorphism (A-842G/C50T) on the occurrence of peptic ulcer hemorrhage by VAN OIJEN, Martijn G. H, LAHEIJ, Robert J. F, KOETSIER, Marjolein, DE KLEINE, Evelien, TE MORSCHE, René H. M, VAN KERKHOVEN, Lieke A. S, JANSEN, Jan B. M. J, DRENTH, Joost P. H

    Published in Digestive diseases and sciences (01-12-2006)
    “…Cyclooxygenases (COX) catalyze the conversion of arachidonic acid to prostaglandins (PGs). COX-inhibiting drugs, such as nonsteroidal anti-inflammatory drugs…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Novel GANAB variants associated with polycystic liver disease by van de Laarschot, Liyanne F M, Te Morsche, René H M, Hoischen, Alexander, Venselaar, Hanka, Roelofs, Hennie M, Cnossen, Wybrich R, Banales, Jesus M, Roepman, Ronald, Drenth, Joost P H

    Published in Orphanet journal of rare diseases (23-10-2020)
    “…Polycystic liver disease (PLD) is an inherited disorder characterized by numerous cysts in the liver. Autosomal dominant polycystic kidney and liver disease…”
    Get full text
    Journal Article
  8. 8

    Short mucin 6 alleles are associated with H pylori infection by Nguyen, Thai V, Janssen, Jr, Marcel, Gritters, Paulien, te Morsche, René H M, Drenth, Joost P H, van Asten, Henri, Laheij, Robert J F, Jansen, Jan B M J

    Published in World journal of gastroenterology : WJG (07-10-2006)
    “…AIM: To investigate the relationship between mucin 6 (MUC6) VNTR length and Hpylori infection. METHODS: Blood samples were collected from patients visiting the…”
    Get full text
    Journal Article
  9. 9

    Severe Polycystic Liver Disease Is Not Caused by Large Deletions of the PRKCSH Gene by Cnossen, Wybrich R., Maurits, Jake S.F., Salomon, Jody, te Morsche, René H.M., Waanders, Esmé, Drenth, Joost P. H.

    Published in Journal of clinical laboratory analysis (01-09-2016)
    “…Background Isolated polycystic liver disease (ADPLD) is an autosomal dominant Mendelian disorder. Heterozygous PRKCSH (where PRKCSH is protein kinase C…”
    Get full text
    Journal Article
  10. 10

    LRP5 variants may contribute to ADPKD by Cnossen, Wybrich R, te Morsche, René H M, Hoischen, Alexander, Gilissen, Christian, Venselaar, Hanka, Mehdi, Soufi, Bergmann, Carsten, Losekoot, Monique, Breuning, Martijn H, Peters, Dorien J M, Veltman, Joris A, Drenth, Joost P H

    Published in European journal of human genetics : EJHG (01-02-2016)
    “…Mutations in Polycystic Kidney Disease proteins (PKD1 or PKD2) are causative for autosomal dominant polycystic kidney disease (ADPKD). However, a small subset…”
    Get full text
    Journal Article
  11. 11

    Cysts of PRKCSH mutated polycystic liver disease patients lack hepatocystin but express Sec63p by Waanders, Esmé, Croes, Huib J. E., Maass, Cathy N., te Morsche, René H. M., van Geffen, Hendrikus J. A. A., van Krieken, J. Han J. M., Fransen, Jack A. M., Drenth, Joost P. H.

    Published in Histochemistry and cell biology (01-03-2008)
    “…Polycystic liver disease (PCLD) is an inherited disorder caused by mutations in either PRKCSH (hepatocystin) or SEC63 (Sec63p). However, expression patterns of…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Cyclooxygenase-2 polymorphisms and the risk of esophageal adeno- or squamous cell carcinoma by Kristinsson, Jón O, van Westerveld, Paul, te Morsche, Rene H M, Roelofs, Hennie M J, Wobbes, T, Witteman, Ben J M, Tan, Adriaan C I T L, van Oijen, Martijn G H, Jansen, Jan B M J, Peters, Wilbert H M

    Published in World journal of gastroenterology : WJG (28-07-2009)
    “…AIM: TO determine whether -1195 A→G and/or -765 G→C polymorphisms in Cyclooxygenase-2 CCOX-2) may have a risk modifying effect on the development of esophageal…”
    Get full text
    Journal Article
  14. 14

    The functional -765G→C polymorphism of the COX-2 gene may reduce the risk of developing crohn's disease by de Vries, Hilbert S, te Morsche, Rene H M, van Oijen, Martijn G H, Nagtegaal, Iris D, Peters, Wilbert H M, de Jong, Dirk J

    Published in PloS one (24-11-2010)
    “…Cyclooxygenase-2 (COX-2) is a key enzyme involved in the conversion of arachidonic acid into prostaglandins. COX-2 is mainly induced at sites of inflammation…”
    Get full text
    Journal Article
  15. 15

    Infliximab Exerts No Direct Hepatotoxic Effect on HepG2 Cells In Vitro by de Vries, Hilbert S., de Heij, Tineke, Roelofs, Henie M. J., te Morsche, Rene H. M., Peters, Wilbert H. M., de Jong, Dirk J.

    Published in Digestive diseases and sciences (01-06-2012)
    “…Background Infliximab-induced hepatotoxicity is reported in several case studies involving patients with inflammatory bowel disease (IBD) and a direct…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Over-expression of COX-2 mRNA in colorectal cancer by Roelofs, Hennie M J, Te Morsche, Rene H M, van Heumen, Bjorn W H, Nagengast, Fokko M, Peters, Wilbert H M

    Published in BMC gastroenterology (02-01-2014)
    “…Cyclooxygenase-2 (COX-2, PTGS2) is an enzyme involved in the synthesis of prostaglandins and thromboxanes, which are regulators of biologic processes such as…”
    Get full text
    Journal Article
  18. 18

    Celecoxib and tauro-ursodeoxycholic acid co-treatment inhibits cell growth in familial adenomatous polyposis derived LT97 colon adenoma cells by van Heumen, Bjorn W.H., Roelofs, Hennie M.J., te Morsche, René H.M., Marian, Brigitte, Nagengast, Fokko M., Peters, Wilbert H.M.

    Published in Experimental cell research (15-04-2012)
    “…Chemoprevention would be a desirable strategy to avoid duodenectomy in patients with familial adenomatous polyposis (FAP) suffering from duodenal adenomatosis…”
    Get full text
    Journal Article
  19. 19

    COX-2 polymorphisms and the risk for head and neck cancer in white patients by Peters, Wilbert H. M., Lacko, Martin, te Morsche, Rene H. M., Voogd, Adri C., Oude Ophuis, Michael B., Manni, Johannes J.

    Published in Head & neck (01-07-2009)
    “…Background. Cyclooxygenase‐2 (COX‐2) is an enzyme involved in the synthesis of prostaglandins and thromboxanes, which are regulators of processes such as…”
    Get full text
    Journal Article
  20. 20